Takeda Announces Candidates for New Directors
Takeda Announces Candidates for New Directors
Osaka, Japan, May 14, 2019, --- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has decided the candidates for new Directors which will be proposed to the 143rd Ordinary General Meeting of Shareholders on June, 2019. The candidates are as follows;
1.Candidates for Non-Audit and Supervisory Committee Directors
Name |
Category |
Current Role | |
Christophe Weber |
Internal |
Existing |
Representative Director, |
Masato Iwasaki |
Internal |
Existing |
Director, President, Japan Pharma Business Unit |
Andrew Plump |
Internal |
Existing |
Director, President, Research & Development |
Constantine Saroukos |
Internal |
New |
Corporate Officer, Chief Financial Officer |
Masahiro Sakane |
External |
Existing |
External Director, Chair of the Board Meeting |
Olivier Bohuon |
External |
Existing |
External Director |
Ian Clark |
External |
Existing |
External Director |
Yoshiaki Fujimori |
External |
Existing |
External Director |
Steven Gillis |
External |
Existing |
External Director |
Toshiyuki Shiga |
External |
Existing |
External Director |
Jean-Luc Butel |
External |
New |
External Director, Audit & Supervisory Committee member |
Shiro Kuniya |
External |
New |
External Director, Head of Audit & Supervisory Committee |
Among the above candidates, Jean-Luc Butel and Shiro Kuniya will resign as Audit & Supervisory Committee Directors at the close of the 143rd Ordinary General Meeting of Shareholders.
2.Candidates for Audit and Supervisory Committee Directors
Name |
Category |
Current Role | |
Emiko Higashi |
External |
New |
External Director |
Michel Orsinger |
External |
New |
External Director |
Audit & Supervisory Committee Directors (Yasuhiko Yamanaka and Koji Hatsukawa) are within their 2-year tenure, and are not subjects for reelection this year.
Media Contact:
Kazumi Kobayashi
[email protected]
+81 (0) 3-3278-2095